India has the fastest-growing pet care market worldwide, with it growing by 14% in 2022, making this an exciting and valuable opportunity for the company.

Hester's comprehensive knowledge of animal biology, cutting-edge R&D capabilities, and four-decade-long experience in animal healthcare gives them an advantage. This expansion perfectly aligns with their core beliefs and vision to provide better health for human beings through healthy animals.

Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and specialty products. The goal is to create and innovate products tailored to pets and their needs.

Hester plans to eventually expand by way of pet biologicals and diagnostics. The complete portfolio will target both veterinarians and pet parents with offerings that cater to the evolving needs of pets.

The Pet Care sector may have started off decades ago as a neglected afterthought but has quickly evolved into an empathetic and emotive sector. Hester's pet care project is tentatively scheduled to hit the floor in April 2022.

Hester Biosciences is one of India's leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country.

The company reported 31% fall in consolidated net profit to Rs 8.48 crore on a 2% decline in revenue from operations to Rs 55.69 crore in Q3 FY22 over Q3 FY21.